Healthcare Resource Utilization and Financial Burden Among Patients With Chronic Hand Eczema – Results From the CHECK Study in the United States
Main Article Content
Keywords
Healthcare resource utilization, burden, Chronic Hand Eczema
References
2. Thyssen JP, Schuttelaar MLA, Alfonso JH, Arents BWM, et al.
Guidelines for diagnosis, prevention, and treatment of hand eczema. Contact Dermatitis. 2022;86(5):357-78.
3. Armstrong A, Hahn-Pedersen J, Bartlett C, Glanville J, & Thyssen JP. Economic burden of chronic hand eczema: a review. American Journal of Clinical Dermatology. 2022;23(3),287-300.
4. Apfelbacher C, Bewley A, Molin S, Fargnoli MC, Giménez-Arnau AM, Brignoli L, Rault B, Norlin JM, Skaaby T, Crépy MN. Prevalence of chronic hand eczema in adults: a cross-sectional survey of over 60,000 respondents from the general population of Canada, France, Germany, Italy, Spain and the UK. Br J Dermatol. 2025;192(6):1047–1054.
5. Coenraads PJ, Van Der Walle H, Thestrup-Pedersen K, Ruzicka T, Dreno B, De La Loge C, et al. Construction and validation of a photographic guide for assessing severity of chronic hand dermatitis.
Br J Dermatol. 2005 Feb;152(2):296–301.
6. Skin Tone Research @ Google AI | Start using the Monk Skin Tone Scale [Internet]. [cited 2025 Jan 31]. Available from: https://skintone.google/get-started
7. Molin S, Crépy M, Fargnoli MC, Apfelbacher C, Brignoli L, Morillo A, Norlin JM,
Didriksen Apol E, Giménez-Arnau AM, Bewley A. Health care visits and out-of-pocket costs in people with Chronic Hand Eczema. Poster presented at: ISPOR Congress; November 2024; Barcelona, Spain
Article Sidebar
Article Details
This work is licensed under a Creative Commons Attribution 4.0 International License.
Creative Commons Attribution (CC BY): lets others distribute and copy the article, to create extracts, abstracts, and other revised versions, adaptations or derivative works of or from an article (such as a translation), to include in a collective work (such as an anthology), to text or data mine the article, even for commercial purposes, as long as they credit the author(s), do not represent the author as endorsing their adaptation of the article, and do not modify the article in such a way as to damage the author's honor or reputation.
Authors retain copyright in their work and license the publisher to publish the content. The publisher is the National Society for Cutaneous Medicine, with production and publishing support provided by OJS, Open Journal Systems,see https://pkp.sfu.
Prior to January 2022, authors transferred copyright to the National Society for Cutaneous Medicine. However, all articles are freely available to anyone in the world. There are no subscription fees, page charges, or article processing charges.